Retina Foundation Presents New Data & Conclusions at ARVO 2018
Development of the first patient-reported outcome measure for quality of life and functional vision designed for children with a broad spectrum of eye conditions.
Discovery that children with strabismus (crossed eyes), anisomteropia (unequal focus between the eyes), or both have unsteady fixation when looking with both eyes.
Reported evidence that treatment for both eyes in children with lazy eyes is more effective than patching in rehabilitating the fellow eye as well as the eye with low vision.
Update on the new technologies capable of identifying and quantifying rod function in the retina for patients with inherited retinal disease.
Reported on our evaluation of the safety and efficacy of a new drug for patients with a juvenile macular degeneration known as Stargardt disease.
Related Articles
Eight New Volunteers Join Board of Directors Age-Related Macular Degeneration Happenings at the Foundation Retina Foundation’s Visionary Luncheon Celebrates Life‑Changing Advancements for Innovative Research and Vision Treatment Retina Foundation to Conduct First Optogenetics Gene Therapy Clinical Trial The Rosewood Foundation And Retina Foundation Of The Southwest Partner Up Again For “Keeping An Eye On Innovation” Series